GLP-1 drugs tied to lower brain inflammation, higher depression risk

- Glucagon-like peptide-1 receptor agonists (GLP-1) drugs are a class of

Northern Trust has enhanced its suite of ex-ante (forward-looking) risk analytics services through the release of its new Market Risk Monitor solution.
The service provides institutional investor clients such as pension funds with an extensive library of key risk indicators